Patterson Cos. (PDCO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Patterson Companies (PDCO) continues to benefit from strength in Animal Health business and robust product portfolio. However, high debt level remains a woe.
On March 16, 2021 the Board of Directors of Patterson Companies, Inc. (Nasdaq: PDCO) approved a new share repurchase authorization for up to $500 million of its common stock through March 16, 2024, replacing a prior authorization which had expired and under which no repurchases had been made.